Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Early research (Phase 1)Study completedNCT02332850
What this trial is testing

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Thomas Martin, MD 83
Testing effectiveness (Phase 2)Study completedNCT01341262
What this trial is testing

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 378
Not applicableUnknownNCT06258096
What this trial is testing

LI-TASTE Study: Light for Taste

Who this might be right for
Multiple Myeloma
Academic Centre for Dentistry in Amsterdam 52
Testing effectiveness (Phase 2)Study completedNCT00081809
What this trial is testing

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Who this might be right for
Lymphoma, FollicularLymphoma, Small Lymphocytic
Agenus Inc. 35
Large-scale testing (Phase 3)Active Not RecruitingNCT06413498
What this trial is testing

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kite, A Gilead Company 452
Not applicableUnknownNCT03201614
What this trial is testing

Comparative Evaluation of A-CP HA Kit, Hyaluronic Acid and Placebo for the Treatment of Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Regen Lab SA 290
Testing effectiveness (Phase 2)Study completedNCT03240133
What this trial is testing

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
BioCryst Pharmaceuticals 58
Large-scale testing (Phase 3)Active Not RecruitingNCT04923893
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 743
Early research (Phase 1)Study completedNCT03007264
What this trial is testing

Cold Plasma for Wound Treatment, Safety Study

Who this might be right for
Intact SkinContaminant Given to Patient
Association of Dutch Burn Centres 25
Not applicableStudy completedNCT03548298
What this trial is testing

Antireflux Ablation Therapy (ARAT) for Gastroesophageal Reflux Treatment

Who this might be right for
Gastro Esophageal Reflux
Coordinación de Investigación en Salud, Mexico 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT03989414
What this trial is testing

Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma
Celgene 424
Large-scale testing (Phase 3)Study completedNCT01910987
What this trial is testing

Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 80
Not applicableStudy completedNCT05979584
What this trial is testing

Platelet Rich Plasma VS Platelet Fibrin Plasma in Treatment of Diabetes Related Wound：a Randomized Controlled Trial

Who this might be right for
Diabetic Foot
Peking University Third Hospital 56
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Not applicableStudy completedNCT01637233
What this trial is testing

MARCH Central Nervous System Substudy

Who this might be right for
HIV-1 Infection
Kirby Institute 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05068830
What this trial is testing

Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Norwegian University of Science and Technology 60
Large-scale testing (Phase 3)Active Not RecruitingNCT00114101
What this trial is testing

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 460
Testing effectiveness (Phase 2)Study completedNCT00783367
What this trial is testing

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Who this might be right for
Follicular LymphomaMarginal Zone B-Cell LymphomaMALT Lymphoma+4 more
Abramson Cancer Center at Penn Medicine 50
Early research (Phase 1)Study completedNCT02852837
What this trial is testing

Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 50
Next Page